S

Stryker

Manufactures orthopedic and surgical medical devices

Regional Sales Manager Joint Replacement

Full-TimeUpdated on 10/23/2026
£57k - £95.1k/yr+ Bonus + Commission
Expert
Bachelor's
Remote in UK
RemoteHome-based; regional travel with regular overnight stays and visits to the Newbury head office.
Sales & Account ManagementField Sales

About the job

Requirements
  • Training in a medical, scientific, or technical career, or a degree in sciences or economics.
  • Verifiable successful sales and/or marketing experience.
  • Experience in team leadership.
  • Anatomical proficiency.
  • Economic knowledge.
  • Commercial skills in leading a profit centre.
  • Knowledge of a customer relationship management system.
  • Knowledge of an enterprise resource planning system.
  • Computer skills, including Microsoft Office.
  • Presentation skills using modern presentation media.
  • Ability to handle communications, criticism, and conflict.
  • Ability to work under pressure.
  • Flexibility to work under pressure and travel regionally, including regular overnight stays away from home.
Responsibilities
  • Exceed and deliver against quarterly and yearly business budgets while managing instrument utilisation, recurring revenue pipeline development, and accurate forecasting against budget.
  • Manage, lead, and motivate a high-performing sales and service team, supporting and driving the team strategically and tactically to accelerate business through the Joint Replacement portfolio.
  • Ensure exceptional service levels are maintained throughout the customer base.
  • Coach and develop the team to achieve its potential.
  • Mentor and develop the clinical, sales, and marketing skills of new hires in the field, and support new starters with information on procedural workflow, daily activity schedules, and role responsibilities.
  • Provide basic Mako platform training during the induction of new Mako Product Specialists, including general instrumentation, implants, and procedural consumables required for each Mako procedure.
  • Register Mako Product Specialists for application training courses through the Mako sales training team in the United Kingdom and Amsterdam.
  • Support new Mako Product Specialists with internal launches and staff training at new Mako installation sites.
  • Coordinate scheduled case coverage across a defined geography and number of Mako Product Specialists, collaborating with the Mako Product Specialist team in Europe and the United States to ensure case coverage.
  • Work with senior hospital staff, customer marketing, and key surgeons to develop and execute plans to increase implant and procedural volume at customer sites.
  • Support and collaborate with enabling function teams, including contracts and pricing, compliance, customer service, and accounting, to maintain a smooth order-to-cash process and high levels of customer service.
  • Build local clinical champions to support the advancement of current and future technology platforms across the portfolio.
  • Understand and utilise market dynamics to support business acceleration.
  • Develop new business creatively for current and future technologies and platforms.
  • Manage the sales area, employees, sales turnover, and costs to optimise customer service and acquire new customers.
  • Make regular customer visits, travel regionally, stay away from home overnight as required, and visit the Newbury head office.
Desired Qualifications
  • Product knowledge in Joint Replacement and robotics segments is ideally desired.

About the company

Stryker makes medical devices for hospitals, surgical centers and emergency responders, spanning joint implants, surgical instruments and patient transport equipment. Its Mako platform assists surgeons with joint replacement, while its neurotechnology products support brain and spine procedures and stroke treatment. Clinicians use its equipment during surgery and emergency care, and the company earns money by selling implants, disposable products and capital equipment through direct sales teams and distributors. The business also supplies training and technical support for healthcare providers using its devices. Stryker was founded in 1941 and is headquartered in Portage, Michigan.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kalamazoo, Michigan

Founded

1941

Get referred to Stryker

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Demand supports growth: July 2026 Stryker results show organic sales rose 9%, with reported sales reaching $6.6 billion.
  • Service extends equipment sales: Stryker's ProCare contracts bundle preventive maintenance, repairs and original manufacturer parts.
  • Relocation is available for Worcester technicians: Stryker's live transport service opening also lists 12 paid holidays.

What critics are saying

  • Operational failures reach customers: March 2026 cyberattack disrupted Stryker's ordering, manufacturing and shipping.
  • Older implants retain legal exposure: Stryker's recall estimates include Rejuvenate, LFIT V40 and legacy Wright hip products.
  • Field service demands travel: Stryker's northern Minnesota opening lists 80% travel plus evening or weekend call.

What makes Stryker unique

  • Mako combines imaging and physical guidance: Stryker uses CT-based planning and haptic boundaries during hip replacement.
  • Discarded devices return to service: Stryker's Sustainability Solutions reprocesses medical equipment for hospitals across the U.S. and Canada.
  • Transport extends its technology outside hospitals: Stryker's Power-LOAD supports stretchers while loading and unloading ambulances.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Medical & prescription plans
  • Supplemental health benefits
  • Flexible Spending accounts
  • Employee Assistance Program
  • Short-term & long-term disability
  • Tuition reimbursement
  • 401(k) plan
  • Employee Stock Purchase Plan

Growth & Insights and Company News

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Oct 21st, 2026
P&G and Stryker: two dividend stocks to hold for decades

Procter & Gamble and Stryker are two dividend stocks suited to long-term holders, according to the article. Both sell products people need in any economy. P&G has raised its dividend for 70 consecutive years. In fiscal 2026, it posted net sales of about $87 billion, up 3%, and net earnings of $16.1 billion. It returned more than $15 billion to shareholders, including $10.2 billion in dividends. Organic sales and core earnings per share each grew just 1%. Stryker has raised its dividend for more than three decades. Second-quarter 2026 revenue rose 9.4% to $6.6 billion, and adjusted earnings per share climbed 17.9% to $3.69. Demand should gain from an ageing US population, though recalls, acquisition costs, and hospital spending pressures remain risks.

Yahoo Finance
Oct 14th, 2026
Stryker wins FDA clearance for Sonopet 3 ultrasonic bone and tissue removal platform

Stryker has received US Food and Drug Administration (FDA) 510(k) clearance for Sonopet 3, the latest version of its ultrasonic bone and soft tissue removal platform. The company announced the news on October 14, 2026. Stryker developed the platform with input from hundreds of surgeons. It offers more power, precision and versatility, along with two technologies: RISE, which connects the surgical workflow, and Pulse Control, which helps regulate the resection of hard and soft tissues. "They told us they wanted more power, improved ergonomics and enhanced integration," said Mitch Foley, vice president and general manager of Stryker's Neurosurgical business. The first clinical cases are expected to begin in October. A full commercial launch is planned for later this fall.

Yahoo Finance
Oct 12th, 2026
Stryker shares fall 20% in six months despite 9.2% organic growth and $25.84B revenue

Stryker (NYSE:SYK) shares have fallen 20% over the past six months to $277.82, while the S&P 500 gained 12.8%. The medical device maker develops orthopedic, surgical, neurotechnology, and patient care products that reach over 150 million patients a year. Organic revenue, which excludes acquisitions, divestitures, and currency swings, grew an average of 9.2% year-on-year over the past two years. That suggests Stryker can expand without costly acquisitions. Revenue over the past 12 months was $25.84 billion. Its scale gives it leverage with suppliers in a heavily regulated, competitive market. Free cash flow margin rose 6.5 percentage points over five years to 18.2% for the trailing 12 months. After the drop, the stock trades at 17.4× forward earnings.

Seeking Alpha
Oct 12th, 2026
Stryker to invest $400M in CMR Surgical, with option to buy the robotics maker outright

Stryker announced a $400 million (£300 million) preferred equity investment in CMR Surgical on Monday. The money will support innovation and global expansion of CMR's Versius surgical robotics portfolio. The deal also gives Stryker an exclusive option to acquire 100% of CMR Surgical.

PR Newswire
Oct 5th, 2026
Stryker launches Mako 4 SmartRobotics in India after 2.5M procedures globally

Stryker has launched Mako 4 SmartRobotics in India, introducing the fourth generation of its robotic-arm assisted technology for joint replacement procedures. The system combines patient-specific planning, robotic technology, and haptic guidance for total knee, partial knee, and total hip applications. Mako 4 uses 3D CT-based planning with AccuStop haptic technology to support surgeons in planning and executing procedures according to individual patient anatomy. The platform provides real-time intraoperative guidance for greater precision during joint replacement procedures. The global Mako platform has supported more than 2.5 million procedures across 47 countries. Aman Rishi, Stryker's vice president and general manager for India, said the launch aims to raise the standard of care and expand access for joint replacement patients nationwide.